Powered by
-Hemispherx Biopharma CEO Discusses 2017 Highlights on CEOLIVE.TV

ORLANDO, Fla. - Hemispherx Biopharma, Inc. (NYSE American: HEB), based in Orlando, FL, focused on pharmaceuticals, today announced that Thomas K. Equels, M.S. J.D., Chief Executive Officer, was interviewed on CEOLIVE.TV on January 2nd, 2018.

http://www.ceolive.tv/hemispherx-heb-going-after-multi-billion-dollar-immuno-oncology-market

The interview can be viewed at:

About Hemispherx Biopharma, Inc.

Hemispherx Biopharma, Inc. is an advanced specialty pharmaceutical company

Sign up for unrestricted access to 200+ subscription services.
Already have an account? Click here to login.

RelSci News & Alerts gets you:

  • 5 free articles a month from top subscription outlets like the Financial Times, New York Times, and Washington Post
  • Competitive business intelligence through daily data updates
  • Custom feeds on target high-value individuals, companies, industries, and topics delivered straight to your inbox